ReviewFrontiers in cellular and infection microbiology2026
Host-response trajectories in necrotizing fasciitis: host-pathogen interactions, immune evasion, and immunoparalysis.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing fasciitis, a prototypical form of necrotizing soft-tissue infection, is a rapidly progressive and life-threatening soft-tissue infection characterized by extensive fascial necrosis, systemic toxicity, tissue hypoperfusion, septic shock, and multiorgan dysfunction. Although early recognition, urgent surgical source control, appropriate antimicrobial therapy, toxin suppression when indicated, and organ support remain the foundations of management, the dynamic host-response states that link microbial virulence, local tissue injury, impaired pathogen clearance, perfusion failure, and secondary immune dysfunction have not been fully integrated into a dedicated immunopathological framework. This Review conceptualizes necrotizing fasciitis as a pathogen-shaped, compartmentalized host-response trajectory in which toxin- and pattern-recognition-driven hyperinflammation, tissue hypoperfusion, impaired pathogen clearance, and counter-regulatory immune dysfunction may overlap across local and systemic compartments. Using group A Streptococcus as an illustrative pathogen, we summarize how superantigens, cytotoxins, immune-evasion programs, complement activation, neutrophil-driven injury, endothelial dysfunction, immunothrombosis, and hypoperfused tissue niches can amplify local destruction while limiting effective immune clearance. We further compare immunopathological differences between group A Streptococcus-predominant monomicrobial disease and polymicrobial infection, emphasizing how pathogen context, host susceptibility, tissue perfusion, and timing of source control may shape divergent clinical trajectories. Clinically relevant approaches for longitudinal host-response assessment are reviewed, including circulating biomarkers, monocytic HLA-DR expression, lymphocyte indices, functional immune profiling, and perfusion-oriented evaluation. Evidence derived from human necrotizing fasciitis or necrotizing soft-tissue infection cohorts is distinguished from mechanistic evidence based on invasive group A Streptococcus models and related sepsis literature. Host-directed immunomodulatory strategies remain largely investigational and should be interpreted through phenotype selection, timing, and evidence-boundary considerations. This host-response trajectory framework may help connect infection biology with immune monitoring, source-control reassessment, antimicrobial therapy, secondary infection surveillance, and phase-informed care. Prospective biomarker-stratified studies are needed to determine whether dynamic immune and perfusion phenotyping can improve survival, limb salvage, wound-bed readiness, reconstructive success, and long-term functional recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.